部位 | ICD-O-3 | 合計 | 男性 | 女性 | |||
---|---|---|---|---|---|---|---|
件数 | % | 件数 | % | 件数 | % | ||
全部位 | 3,226 | 100.0% | 1,695 | 100.0% | 1,531 | 100.0% | |
頭頸部 | C00-C14 C30-C32 | 180 | 5.6% | 125 | 7.4% | 55 | 3.6% |
食道 | C15 | 227 | 7.0% | 191 | 11.3% | 36 | 2.4% |
胃 | C16 | 236 | 7.3% | 168 | 9.9% | 68 | 4.4% |
大腸 | C18-C20 | 223 | 6.9% | 133 | 7.8% | 90 | 5.9% |
( 結腸 ) | C18 | 144 | 4.5% | 81 | 4.8% | 63 | 4.1% |
( 直腸S状結腸移行部、直腸) | C19-C20 | 79 | 2.4% | 52 | 3.1% | 27 | 1.8% |
膵 | C25 | 168 | 5.2% | 87 | 5.1% | 81 | 5.3% |
気管、気管支及び肺 | C33-C34 | 229 | 7.1% | 152 | 9.0% | 77 | 5.0% |
血液、骨髄 | C420-C421 | 105 | 3.3% | 64 | 3.8% | 41 | 2.7% |
皮膚(黒色腫以外) | C44 | 103 | 3.2% | 62 | 3.7% | 41 | 2.7% |
乳房 | C50 | 316 | 9.8% | 0 | 0.0% | 316 | 20.6% |
子宮 | C53-C55 | 212 | 6.6% | - | - | 212 | 13.8% |
( 子宮頚 ) | C53 | 112 | 3.5% | - | - | 112 | 7.3% |
( 子宮体部 ) | C54 | 100 | 3.1% | - | - | 100 | 6.5% |
( 子宮NOS ) | C55 | 0 | 0.0% | - | - | 0 | 0.0% |
前立腺 | C61 | 205 | 6.4% | 205 | 12.1% | - | - |
髄膜、脳、脊髄、脳神経及びその他の中枢神経系 | C70-C72 | 173 | 5.4% | 76 | 4.5% | 97 | 6.3% |
悪性リンパ腫 | M959-M972 | 167 | 5.2% | 73 | 4.3% | 94 | 6.1% |
その他(100件未満) | 682 | 21.1% | 359 | 21.2% | 323 | 21.1% |
※4 登録症例が年間100例に満たないものはその他に含みます。
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 93.8% | 90.9% | 100.0% | 17.9% | 100.0% | 0.0% | 83.1% |
手術 | 30.0% | 90.9% | 100.0% | 14.3% | 28.6% | 0.0% | 33.3% |
(うち、体腔鏡的治療) | 24.6% | 27.3% | 16.7% | 3.6% | 7.1% | 0.0% | 20.1% |
内視鏡的治療 | 65.4% | 0.0% | 0.0% | 3.6% | 71.4% | 0.0% | 50.8% |
放射線療法 | 0.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.5% |
化学療法 | 6.2% | 45.5% | 50.0% | 89.3% | 0.0% | 0.0% | 21.7% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 100.0% | 100.0% | 100.0% | 94.4% | 72.7% | 95.5% | 0.0% | 95.7% |
手術 | 16.7% | 82.4% | 100.0% | 94.4% | 72.7% | 31.8% | 0.0% | 65.2% |
(うち、体腔鏡的治療) | 16.7% | 70.6% | 58.3% | 66.7% | 9.1% | 9.1% | 0.0% | 42.6% |
内視鏡的治療 | 88.9% | 23.5% | 0.0% | 0.0% | 0.0% | 63.6% | 0.0% | 33.0% |
放射線療法 | 0.0% | 0.0% | 8.3% | 11.1% | 0.0% | 0.0% | 0.0% | 2.6% |
化学療法 | 5.6% | 2.9% | 16.7% | 33.3% | 90.9% | 13.6% | 0.0% | 20.0% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 40.0% | 50.0% | 57.1% | 12.5% | 0.0% | 60.0% | 42.9% |
手術 | 40.0% | 45.0% | 57.1% | 0.0% | 0.0% | 60.0% | 40.0% |
(うち、体腔鏡的治療) | 13.3% | 5.0% | 0.0% | 0.0% | 0.0% | 0.0% | 7.1% |
内視鏡的治療 | 0.0% | 5.0% | 0.0% | 12.5% | 0.0% | 0.0% | 2.9% |
放射線療法 | 0.0% | 5.0% | 14.3% | 25.0% | 0.0% | 0.0% | 5.7% |
化学療法 | 20.0% | 40.0% | 42.9% | 87.5% | 0.0% | 60.0% | 38.6% |
TAE | 46.7% | 50.0% | 42.9% | 12.5% | 0.0% | 0.0% | 40.0% |
レーザー等治療 | 30.0% | 0.0% | 28.6% | 0.0% | 0.0% | 0.0% | 15.7% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 82.8% | 82.4% | 13.5% | 7.5% | 100.0% | 0.0% | 45.7% |
手術 | 82.8% | 82.4% | 13.5% | 7.5% | 100.0% | 0.0% | 45.7% |
(うち、体腔鏡的治療) | 82.8% | 64.7% | 0.0% | 5.7% | 100.0% | 0.0% | 40.6% |
内視鏡的治療 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
放射線療法 | 17.2% | 11.8% | 73.0% | 45.3% | 0.0% | 0.0% | 36.6% |
化学療法 | 4.7% | 17.6% | 67.6% | 69.8% | 0.0% | 0.0% | 38.9% |
その他 | 0.0% | 0.0% | 0.0% | 1.9% | 0.0% | 0.0% | 0.6% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術の割合 | 100.0% | 96.6% | 84.1% | 81.3% | 10.0% | 100.0% | 0.0% | 87.3% |
放射線療法 | 36.1% | 44.8% | 31.8% | 68.8% | 30.0% | 100.0% | 0.0% | 41.2% |
化学療法 | 2.8% | 32.8% | 65.9% | 68.8% | 80.0% | 0.0% | 0.0% | 41.2% |
内分泌療法 | 36.1% | 72.4% | 45.5% | 56.3% | 30.0% | 0.0% | 0.0% | 52.7% |
(重複あり)